CM
NVNO

CM Management’s enVVeno Medical NVNO Stock Holding History

CM Management’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$382K Hold
35,714
– – 0.24% 69
2026
Q1 		$362K Hold
35,714
– – 0.3% 66
2025
Q4 		$401K Buy
35,714
+18,571
+108% +$361K 0.34% 55
2025
Q3 		$544K Buy
+17,143
New +$1.75M 0.45% 55

Other funds holding NVNO

KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
APW
Allied Private Wealth Boca Raton, Florida $156M AUM

CM Management's NVNO Position: Q2 2026 in Review

CM Management held its enVVeno Medical (NVNO) position steady in Q2 2026 at 35,714 shares worth $382K. The position accounts for 0.24% of the portfolio, ranked #69.

CM Management first reported a position in NVNO in Q3 2025 and has held it in 4 quarters since. The position peaked at $544K in Q3 2025. 17 funds tracked by Wall St. Rank hold NVNO as of Q2 2026.

  • CM Management held 35,714 shares of enVVeno Medical worth $382K as of Q2 2026.
  • CM Management left its enVVeno Medical share count unchanged in Q2 2026.
  • enVVeno Medical made up 0.24% of CM Management's portfolio in Q2 2026, its #69 holding.
  • CM Management first reported a position in enVVeno Medical in Q3 2025 and has held it in 4 quarters since.
  • CM Management's enVVeno Medical position peaked at $544K in Q3 2025.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2026.

Based on CM Management's 13F filing for Q2 2026, filed 13 Aug 2026.